This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
B cell (Raji)
Blood
Bone marrow stromal cells
Bone marrow-derived mesenchymal stem cell (R14)
Breast cancer cell (MCF7)
Breast cancer cells (MDA-MB-231)
Colorectal cancer cell (SW480)
Colorectal cancer cell (SW620)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cell (DMS563)
Lung cancer cell (NCI_H69)
Lung cancer cell (SBC-3)
Lung cancer cells (A549)
Mammary gland cells (MCF10A)
Metastatic gastric cacncer cell (AZP7a)
Metastatic gastric cancer cell (AZ521)
Multiple myeloma cells (RPMI8226)
Oral cancer cells (HOC313-LM)
Oral cancer cells (HOC313-P)
Pancreatic cancer cells (AsPC1, BxPC3, Capan1, Capan2, MiaPaca2, Panc1, Pt45P1, A818, Colo357, HD3577)
Plasma
Primary dendritic cell
Seminal plasma
Serum
T cell (Jurkat)
By sample status
Cisplatin-resistant
Colorectal cancer_stage1
Colorectal cancer_stage2
Colorectal cancer_stage3a
Colorectal cancer_stage3b
Colorectal cancer_stage4
Electroporated with Dicer antibody
Healthy_timepoint1
Healthy_timepoint2
Multiple myeloma patients
Multiple sclerosis
Normal
Normal_Agilent
Normal_Exiqon
Pancreatic cancer patient_Agilent
Pancreatic cancer patient_Exiqon
Pollen allergy_timepoint1
Sample A_Biooscientific
Sample A_Illumina
Sample A_NEB
Sample B_Biooscientific
Sample B_NEB
Sample C_NEB
Type 1 diabetes
Vasectomy
Vasovasostomy
shDicer-transfected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-let-7a-5p
MIMAT0000062
0.0e+0
2.3e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
5.0e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
2.8e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
7.5e-11
Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles includes microRNA-like tRNA Fragments.
Mol Cancer Res. 2015 Feb 26. pii: molcanres.0533.2014.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
9.7e-4
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
9.1e-3
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
4.2e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
3.3e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
4.0e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
3.6e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
7.9e-8
3.1e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
1.1e-11
2.5e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
2.3e-2
2.3e-2
Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis.
Nat Commun. 2018 Jan 2;9(1):17. doi: 10.1038/s41467-017-02406-2.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
2.2e-2
2.2e-2
Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis.
Nat Commun. 2018 Jan 2;9(1):17. doi: 10.1038/s41467-017-02406-2.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
8.2e-4
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
0.0e+0
2.6e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
1.9e-3
1.9e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000002_1
115
/
0
/
115
hsa-let-7a-5p
MIMAT0000062
3.6e-3
3.6e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000002_1
115
/
0
/
115
<
[2]